Atkins Michael B.

Atkins Michael B. is listed in filings as Director at Werewolf Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 13, 2025, including 1 public disclosure. Recent filings connect the profile to Werewolf Therapeutics, Inc. (HOWL). The current snapshot covers public activity from Jun 13, 2025. Reported amounts are shown as $34.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.